Skip to content

The role of planned radiotherapy in laryngeal function preservation in patients with advanced hypopharyngeal cancer

The role of planned radiotherapy in laryngeal function preservation in patients with advanced hypopharyngeal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020966
Enrollment
Unknown
Registered
2019-01-23
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypopharyngeal carcinoma

Interventions

Radiotherapy sensitive patients and radiotherapy insensitive patients:NA

Sponsors

Shandong Provincial ENT Hospital, Shandong Provincial ENT Hospital affiliated to Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Tumors are confined to the hypopharynx and can be resected before or after radiotherapy; 2. Neck lymph nodes can be resected or radiotherapy can be resected; 3. No distant metastasis; 4. HPV (-), Long-term Tobacco and Alcohol Stimulation; 5. Life expectancy is 12 months; 6. Aged 18-75 years old male and female; 7. The general status is at ECOG 0-2 level; 8. Cardiopulmonary function can tolerate radiotherapy and surgery; 9. Blood routine and liver and kidney function can tolerate radiotherapy and surgery; 10. No other severe radiotherapy or surgical contraindications were found; 11. Volunteer to participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with dual or multiple primary tumors or distant metastases were also present; 2. Those who can not give up smoking and alcohol during treatment; 3. Non-smoking and alcohol stimulation; 4. Pregnant and lactating women; 5. Active gastrointestinal bleeding; 6. Uncontrollable diabetes, hypertension; 7. Those who need systemic steroid therapy; 8. Other serious diseases such as myocardial infarction, malignant hypertension and chronic pancreatitis occurred within 6 months; 9. At present or within four weeks to participate in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Sensitivity-related factors about radiotherapy;

Countries

China

Contacts

Public ContactWei Xu

Shandong Provincial ENT Hospital, Shandong Provincial ENT Hospital affiliated to Shandong University

xuwhns@126.com+86 13853190736

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026